FluMist Shedding Studies Needed To More Clearly Define Transmission Rate

MedImmune/Wyeth FluMist shedding studies are needed to more clearly define the probability of transmitting the influenza vaccine virus to a high-risk patient, FDA's Vaccine & Related Biological Products Advisory Committee recommended Dec. 17